Annual report pursuant to Section 13 and 15(d)

Income Taxes - Schedule of Deferred Tax Assets and Liabilities (Details)

v3.6.0.2
Income Taxes - Schedule of Deferred Tax Assets and Liabilities (Details) - USD ($)
$ in Thousands
Dec. 31, 2016
Dec. 31, 2015
Dec. 31, 2014
Income Tax Disclosure [Abstract]      
Net operating loss and capital loss carryforward $ 18,019 $ 16,921 $ 14,983
Consulting-royalty costs (8) 39
Trademark 576 671 752
Investment in Phusion 938 1,103 (483)
Depreciation (304) (103) (45)
Other 1,159 802 2,508
Valuation allowance (20,388) (19,386) (17,754)
Total